Complex/cryptic EWSR1::FLI1/ERG gene fusions and 1q jumping translocation in pediatric Ewing sarcomas Journal Article


Authors: Zou, Y. S.; Morsberger, L.; Hardy, M.; Ghabrial, J.; Stinnett, V.; Murry, J. B.; Long, P.; Kim, A.; Pratilas, C. A.; Llosa, N. J.; Ladle, B. H.; Lemberg, K. M.; Levin, A. S.; Morris, C. D.; Haley, L.; Gocke, C. D.; Gross, J. M.
Article Title: Complex/cryptic EWSR1::FLI1/ERG gene fusions and 1q jumping translocation in pediatric Ewing sarcomas
Abstract: Ewing sarcomas (ES) are rare small round cell sarcomas often affecting children and characterized by gene fusions involving one member of the FET family of genes (usually EWSR1) and a member of the ETS family of transcription factors (usually FLI1 or ERG). The detection of EWSR1 rearrangements has important diagnostic value. Here, we conducted a retrospective review of 218 consecutive pediatric ES at diagnosis and found eight patients having data from chromosome analysis, FISH/microarray, and gene-fusion assay. Three of these eight ES had novel complex/cryptic EWSR1 rearrangements/fusions by chromosome analysis. One case had a t(9;11;22)(q22;q24;q12) three-way translocation involving EWSR1::FLI1 fusion and 1q jumping translocation. Two cases had cryptic EWSR1 rearrangements/fusions, including one case with a cryptic t(4;11;22)(q35;q24;q12) three-way translocation involving EWSR1::FLI1 fusion, and the other had a cryptic EWSR1::ERG rearrangement/fusion on an abnormal chromosome 22. All patients in this study had various aneuploidies with a gain of chromosome 8 (75%), the most common, followed by a gain of chromosomes 20 (50%) and 4 (37.5%), respectively. Recognition of complex and/or cryptic EWSR1 gene rearrangements/fusions and other chromosome abnormalities (such as jumping translocation and aneuploidies) using a combination of various genetic methods is important for accurate diagnosis, prognosis, and treatment outcomes of pediatric ES. © 2023 by the authors.
Keywords: controlled study; treatment outcome; bone neoplasms; bone tumor; gene translocation; major clinical study; genetics; outcome assessment; gene; cohort analysis; retrospective study; ewing sarcoma; sarcoma; rna binding protein; rna-binding proteins; chromosome aberration; fluorescence in situ hybridization; gene rearrangement; microarray analysis; molecular recognition; gene fusion; transcription factor erg; translocation, genetic; chromosome aberrations; chromosome 8; rna binding protein ews; transcription factor fli 1; chromosome analysis; calmodulin binding protein; ewsr1 protein, human; calmodulin-binding proteins; aneuploidy; rna-binding protein ews; chromosome 22; chromosome 20; chromosome 4; ewsr1 gene; sarcoma, ewing; humans; prognosis; human; male; article; erg protein, human; ewing sarcomas; transcriptional regulator erg; 1q jumping translocation; cryptic translocation; ewsr1::erg gene fusion; ewsr1::fli1 gene fusions; three-way translocation
Journal Title: Genes
Volume: 14
Issue: 6
ISSN: 2073-4425
Publisher: MDPI  
Date Published: 2023-06-01
Start Page: 1139
Language: English
DOI: 10.3390/genes14061139
PUBMED: 37372318
PROVIDER: scopus
PMCID: PMC10298448
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Carol Morris
    79 Morris